+$61.8M
Net Activity
Institutions Holding
130
Popularity Rank
#3881
Avg Weight
0.04%
Total Value
$178.6M
130 institutions currently hold ANIK, with 70 net buyers and 57 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
57
Net Buying Institutions
70
Top 5 by Value
+$67.9M
Total Buy Value
$57.1M
Total Sell Value
70
Net Buyers
57
Net Sellers
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Anika Therapeutics amended its credit line with Bank of America on July 10, 2026, increasing the total available to as much as $100 million. The revolving facility starts at $50 million with an option to borrow an additional $50 million. The loan matures in 2031, and interest is SOFR plus a margin based on the company's leverage. Anika pledged substantially all of its assets as collateral.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter